Immune Cell Infiltration Characteristics in the Tumor Microenvironment of Triple-Negative Breast Cancer and Their Prognostic Value
Yun Liu ( The Sixth Medical Center of the PLAGeneral Hospital, Beijing 100000, China )
https://doi.org/10.37155/2717-5278-0702-2Abstract
Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, rendering endocrine therapy and anti-HER2 targeted therapy inefective. As a result, therapeutic options for TNBC are limited, and the prognosis remains poor. In recent years, with the successful application of immunotherapy in various solid tumors, TNBC—recognized as the most immunogenic subtype of breast cancer—has attracted increasing attention, particularly regarding the immune cell infiltration patterns within its Tumor Microenvironment (TME). This review systematically summarizes the composition, functional states, spatial distribution, and interaction networks of key immune cell populations in the TNBC TME, including tumor-
infiltrating lymphocytes (TILs), myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), and regulatory T cells (Tregs). Furthermore, it comprehensively discusses the associations between these immune infiltration characteristics and clinicopathological features, therapeutic responses, and long-term survival outcomes of patients. This review aims to provide a theoretical basis and novel insights for the development of precision immunotherapy strategies in TNBC.
Keywords
Triple-negative breast cancer; tumor microenvironment; immune cell infltration; tumor-infltrating lymphocytes; prognosis; immunotherapyFull Text
PDFReferences
[2]Lu Xudong. The value of MRI multimodal parameters in predicting histopathological grading of triple-negative breast cancer. Imaging Research and Medical Applications, 2026, 10(02): 83–85.
[3]Ren Shasha. Factors influencing poor prognosis in young female patients with triple-negative breast cancer. Chinese Journal of MinKang Medicine, 2026, 38(01): 19–21, 25.
[4]Chen Juhua, Kan Binghua, Zhang Hongwei, et al. Immunohistochemistry-based classification of triple-negative breast cancer and its prognostic implications. Chinese Journal of Experimental Diagnostics, 2025, 29(09): 993–1000.
Copyright © 2025 Yun Liu
Publishing time:2025-04-30
This work is licensed under a Creative Commons Attribution 4.0 International License